The Effectiveness of Bu Zhong Yi Qi Tang in Patients with Myasthenia Gravis

Last updated: March 17, 2025
Sponsor: Cheng, yu-ting
Overall Status: Active - Recruiting

Phase

N/A

Condition

Sarcopenia

Neuropathy

Polymyositis (Inflammatory Muscle Disease)

Treatment

Bu Zhong Yi Qi Tang

caramel dyed starch placebo

Clinical Study ID

NCT06881173
20220305R
  • Ages > 20
  • All Genders

Study Summary

Research Background: According to the Myasthenia Gravis Foundation of America (MGFA, 2015), the estimated prevalence of myasthenia gravis is 14-20 per 100,000 people, with a higher prevalence in young female individuals compared to males. However, as individuals age, especially after the age of 50, the prevalence in males becomes higher than in females. myasthenia gravis patients often experience varying degrees of disability, leading to the need for long-term medical care, medication, and lifestyle adjustments. This also gives rise to subsequent challenges in caregiving, affecting both the patients' families and society.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients diagnosed with ocular myasthenia by a doctor

  • Western medicine prescriptions only take oral Mestinon (Pyrido stigmine Bromide)

  • Patients over 20 years old

  • Can understand and understand Those who can speak Mandarin or Taiwanese

  • those with a clear state of consciousness and no diagnosis of mental illness

  • patients and their families who are willing to receive precise integrated treatmentof traditional Chinese and Western medicine.

Exclusion

Exclusion Criteria:

  • Patients with liver failure or kidney failure

  • Allergy symptoms to traditional Chinese medicine, such as skin itching and redness

  • Patients with malignant tumors

  • Patients currently undergoing radiotherapy and chemotherapy

  • Pregnant

  • Cardiac rhythm device implementer

Study Design

Total Participants: 112
Treatment Group(s): 2
Primary Treatment: Bu Zhong Yi Qi Tang
Phase:
Study Start date:
June 14, 2022
Estimated Completion Date:
June 13, 2025

Study Description

:This study aims to assess the effectiveness of using a combination of traditional Chinese and Western medicine,to improve the meridian energy and autonomic nervous system function of myasthenia gravis patients.

Connect with a study center

  • Shin Kong Wu Ho-Su Memorial Hospital

    Taipei,
    Taiwan

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.